Cornea / Ocular Surface

What will management of the disability look like in 10 years?

What if, instead of waiting for a donor cornea to become available, you could just print one?

In their niche, LESCs interact closely with extracellular matrix components, melanocytes, immune cells, blood vessels, nerves and MSCs.

MSCs are a viable option for the management of LCSD, and should be pursued in carefully designed clinical trials.

Copper drops for the treatment of keratoconus.

The secret to managing irregular astigmatism during cataract surgery? Tackling the problem at its source.

Kinoshita’s CEC+ROCK approach to treating corneal endothelial cell dystrophies enters the clinic.

Combating Acanthamoeba keratitis with plasma-activated water.

We analyze the clinicaltrials.gov corneal clinical trial dataset, to gain insight.

CEO of SightLife Surgical